Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-117180
Filing Date
2024-10-24
Accepted
2024-10-24 21:24:27
Documents
2
Period of Report
2024-10-24

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 5466
2 EX-24 ck0001984086-ex24.htm EX-24 14900
  Complete submission text file 0000950170-24-117180.txt   21831
Mailing Address C/O PLIANT THERAPEUTICS, INC. 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Coulie Bernard (Reporting) CIK: 0001808895 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42382 | Film No.: 241393881

Mailing Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080
Business Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080 650-338-3533
Septerna, Inc. (Issuer) CIK: 0001984086 (see all company filings)

EIN.: 843891440 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)